300009 安科生物
按盤價 
10.010 -0.080 (-0.793%)
10.010 -0.080 (-0.793%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 9.056 | 17.985 | 24.395 | 23.461 | 7.350 |
| 總資產報酬率 ROA (%) | 7.288 | 14.018 | 18.403 | 17.746 | 5.761 |
| 投入資產回報率 ROIC (%) | 8.841 | 17.522 | 23.685 | 22.864 | 7.233 | 邊際利潤分析 |
| 銷售毛利率 (%) | 76.449 | 77.394 | 78.353 | 78.406 | 80.062 |
| 營業利潤率 (%) | 33.457 | 31.797 | 32.242 | 36.121 | 13.715 |
| 息稅前利潤/營業總收入 (%) | 33.658 | 31.599 | 31.968 | 35.668 | 13.281 |
| 淨利潤/營業總收入 (%) | 28.986 | 28.227 | 29.960 | 31.645 | 9.378 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.168 | 94.034 | 101.666 | 92.447 | 207.494 |
| 價值變動淨收益/利潤總額(%) | 2.361 | 3.232 | -0.560 | 4.929 | 8.622 |
| 營業外收支淨額/利潤總額(%) | -0.058 | -0.421 | -0.440 | -0.977 | -0.786 | 償債能力分析 |
| 流動比率 (X) | 3.359 | 3.408 | 2.745 | 2.827 | 3.066 |
| 速動比率 (X) | 2.900 | 2.963 | 2.468 | 2.516 | 2.777 |
| 資產負債率 (%) | 15.829 | 16.268 | 20.571 | 20.089 | 20.864 |
| 帶息債務/全部投入資本 (%) | -1.599 | -1.573 | -1.701 | -2.329 | -2.970 |
| 股東權益/帶息債務 (%) | -6,106.939 | -6,203.621 | -5,718.036 | -4,160.325 | -3,302.521 |
| 股東權益/負債合計 (%) | 509.525 | 493.686 | 366.977 | 375.201 | 364.013 |
| 利息保障倍數 (X) | 152.692 | -488.601 | -240.501 | -347.433 | -40.631 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 61.728 | 70.448 | 59.994 | 64.782 | 69.678 |
| 存貨周轉天數 (天) | 172.001 | 167.191 | 129.323 | 140.078 | 140.021 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 26/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
